Schrodinger Inc (SDGR)

08:45 AM

Schrödinger to Announce Second Quarter 2025 Financial Results on August 6 | SDGR Stock News - GuruFocus

08:45 AM

08:30 AM

Schrödinger to Announce Second Quarter 2025 Financial Results on August 6 - Yahoo Finance

08:30 AM

Jul 24, 2025

Is Schrödinger Inc. stock overhyped or has real potentialExceptional profit velocity - jammulinksnews.com

Jul 24, 2025

Jul 24, 2025

Schrodinger, Inc. (SDGR) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release - MSN

Jul 24, 2025

Jul 23, 2025

Is Schrödinger Inc. a good long term investmentPowerful market insights - Autocar Professional

Jul 23, 2025

Jul 23, 2025

Schrödinger Inc. Stock Analysis and ForecastFree Stock Selection - jammulinksnews.com

Jul 23, 2025

Jul 23, 2025

What drives Schrödinger Inc. stock priceTremendous gains - Autocar Professional

Jul 23, 2025

Jul 22, 2025

What analysts say about Schrödinger Inc. stockSuperior stock growth - jammulinksnews.com

Jul 22, 2025

Jul 18, 2025

Material Informatics Company Evaluation Report 2025 | Schrodinger, Dassault Systèmes, and Citrine Informatics Drive Market Growth Through AI, Simulation, and Collaboration - Yahoo Finance

Jul 18, 2025

Jul 18, 2025

When the Price of (SDGR) Talks, People Listen - news.stocktradersdaily.com

Jul 18, 2025

Jul 18, 2025

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance

Jul 18, 2025

Jul 17, 2025

Ajax Therapeutics and Schrödinger expand JAK inhibitor collaboration By Investing.com - Investing.com Nigeria

Jul 17, 2025

Jul 17, 2025

Schrodinger stock maintains Buy rating at Citi on Ajax collaboration By Investing.com - Investing.com Canada

Jul 17, 2025

Jul 17, 2025

Schrodinger stock maintains Buy rating at Citi on Ajax collaboration - Investing.com

Jul 17, 2025

Jul 17, 2025

Ajax Therapeutics and Schrödinger expand JAK inhibitor collaboration - Investing.com

Jul 17, 2025

Jul 17, 2025

Ajax Therapeutics and Schrödinger Expand Research Collaboration to Include Additional JAK Target - Business Wire

Jul 17, 2025

Jul 16, 2025

Can Recursion Pharmaceuticals' Strategic Deals Fuel Long-Term Growth? - Barchart.com

Jul 16, 2025

Jul 14, 2025

What makes Schrödinger Inc. stock price move sharplyMoney Making Low Risk Plans - beatles.ru

Jul 14, 2025

Jul 12, 2025

Morgan Stanley Assumes Coverage on Schrödinger (SDGR) Stock - MSN

Jul 12, 2025

Jul 10, 2025

BMO Capital Remains a Buy on Schrodinger (SDGR) - The Globe and Mail

Jul 10, 2025

Jul 07, 2025

(SDGR) On The My Stocks Page - news.stocktradersdaily.com

Jul 07, 2025

Jul 06, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc.SDGR - FinancialContent

Jul 06, 2025

Jul 04, 2025

Schrödinger (SDGR) Receives FDA Fast Track Designation for Cancer Drug SGR-1505 - MSN

Jul 04, 2025

Jul 03, 2025

Schrodinger stock rating assumed by Morgan Stanley at Equalweight - Investing.com India

Jul 03, 2025

Jul 01, 2025

Schrödinger Demonstrates Corporate Sustainability Progress in 2024 Report - ReportAlert

Jul 01, 2025

Jun 29, 2025

Schrödinger gets Fast Track status for SGR-1505 - MSN

Jun 29, 2025

Jun 27, 2025

Schrödinger (SDGR) Gains FDA Fast Track for MALT1 Inhibitor - GuruFocus

Jun 27, 2025

Jun 27, 2025

Schrödinger Receives Fast Track Designation for SGR-1505 for the Treatment of Relapsed/Refractory Waldenström Macroglobulinemia | SDGR Stock News - GuruFocus

Jun 27, 2025

Jun 27, 2025

Schrödinger gets Fast Track status for SGR-1505 (SDGR:NASDAQ) - Seeking Alpha

Jun 27, 2025

Jun 18, 2025

Schrodinger Announces Board Elections and Approvals - TipRanks

Jun 18, 2025